lobbying_activities: 1183856

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1183856	20b8f89e-c61f-4d40-b6a1-3913a00655d6	Q4	BUCHANAN INGERSOLL & ROONEY PC	55291	SHIRE PHARMACEUTICALS INC	2011	fourth_quarter	PHA	Life Sciences Investment Act; ESRD orphan drugs; health care reform implementation; DEA Quotas; Drug shortage; CMS issues; PDUFA; exclusivity periods	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2012-01-11T17:17:20-05:00